230-kDa and 190-kDa proteins in addition to desmoglein 1 as immunological targets in a subset of pemphigus foliaceus with a combined cell-surface and basement membrane zone immune staining pattern

Experimental Dermatology

Volumn 12, Issue 5, 2003, Pages 646-654

  Karlhofer, Franz M ^a   Hashimoto, T ^b   Slupetzky, K ^a   Kiss, M ^c   Liu, Y ^b   Amagai, M ^d   Pieczkowski, F ^a   Foedinger, D ^a   Kirnbauer, R ^a   Stingl, G ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF SZEGED   (Hungary)

^d KEIO UNIVERSITY   (Japan)

Author keywords

BP230; Desmoglein 1; ELISA; Pemphigus erythematosus; Pemphigus foliaceus; Periplakin; Superficial pemphigus

Indexed keywords

ANTIGEN; ANTIRHEUMATIC AGENT; AUTOANTIBODY; BULLOUS PEMPHIGOID ANTIGEN 1; DAPSONE; DESMOGLEIN 1; DESMOGLEIN 3; GOLD; METHOTREXATE; METHYLPREDNISOLONE; PENICILLAMINE; PERIPLAKIN; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ACANTHOLYSIS; ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; APHERESIS; ARTICLE; BASEMENT MEMBRANE; CASE REPORT; CELL SURFACE; CLINICAL FEATURE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMATOUS PEMPHIGUS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR DYNAMICS; PATHOGENESIS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; SKIN DISEASE;

ADULT; ANTIGENS, SURFACE; AUTOANTIBODIES; AUTOANTIGENS; BASEMENT MEMBRANE; CADHERINS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; DESMOGLEIN 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; NERVE TISSUE PROTEINS; PEMPHIGUS; PLAKINS;

EID: 12444255156     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2003.00103.x     Document Type: Article

References (51)

1. Stanley J R. Pemphigus. In: Freedberg I, M, Eisen A Z Wolff K et al., eds. Dermatology in General Medicine, 5th edn. New York, NY: Mc Graw-Hill, 1999: 654-666.
2. Amagai M. Pemphigus: Autoimmunity to epidermal cell adhesion molecules. Adv Dermatol 1996: 11: 319-353.
3. Amagai M, Komai A, Hashimoto T, et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999: 140: 351-357.
4. Gomi H, Kawada A, Amagai M, Matsuo I. Pemphigus erythematosus: Detection of anti-desmoglein 1 antibodies by ELISA. Dermatol 1999: 199: 188-189.
5. Perry H O, Brunsting L A. Pemphigus foliaceus: Further observations. Arch Dermatol 1965: 91: 10-23.
6. Senear F E, Usher B. An unusual type of pemphigus combining features of lupus erythematosus. Arch Dermatol Syphilol 1926: 13: 761-781.
7. Jablonska S, Chorzelski T, Lebioda J. Koexistenz von Pemphigus erythematosus und Myasthenia gravis. Hautarzt 1970: 21: 156-160.
8. Maize J C, Green D, Provost T T. Pemphigus foliaceus. A case with serologic features of Senear-Usher syndrome and other autoimmune abnormalities. J Am Acad Dermatol 1982: 7: 736-741.
9. Willemsen M J, DeConinck A L, DeRaeve L E, Roseeuw D I. Penicillamine induced pemphigus erythematosus. Int J Dermatol 1990: 29: 193-197.
10. Lyde C B, Cox S E, Cruz P D. Pemphigus erythematosus in a five-year-old child. J Am Acad Dermatol 1994: 31: 906-909.
11. Chorzelski T, Jablonska S, Blaszczyk M. Immunopathological investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus). Br J Dermatol 1968: 80: 211-217.
12. Amerian M L, Ahmed A R. Pemphigus erythematosus Senear-Usher syndrome. Int J Dermatol 1985: 24: 16-25.
13. Jablonska S, Chorzelski T, Blaszczyk M, Maciejewski W. Pathogenesis of pemphigus erythematosus. Arch Derm Res 1977: 258: 135-140.
14. Orfanos C E, Gartmann H, Mahrle G. Zur Pathogenese des Pemphigus eryhtematosus. Übergang eines chronischen discoiden Erythematodes in einen Pemphigus erythematosus (Senear-Usher). Arch Derm Forsch 1971: 240: 317-333.
15. Ngo A W, Straka C, Fretzin D. Pemphigus erythematosus: A unique association with systemic lupus erythematosus. Cutis 1985: 38: 160-163.
16. Beutner E H, Chorzelski T P, Hale W L, Hausmanowa-Petrusewicz I. Autoimmunity in concurrent myasthenia gravis and pemphigus erythematosus. JAMA 1968: 203: 125-129.
17. Wilhelm T, Metz J, Deuchert K. Pemphigus erythematosus und malignes Thymom. Hautarzt 1982: 33: 156-158.
18. Fuxiang G, Beutner E H. Pemphigus erythematosus associated with thymoma: A case report. Cutis 1999: 64: 179-182.
19. Scherak O, Kolarz G, Holubar K. Pemphigus erythematosus-like rash in a patient on penicillamine. Br Med J 1977: 26: 838.
20. Burnham T K, Neblett T R, Fine G. The application of the fluorescent antibody technique to the investigation of lupus erythematosus and various dermatoses. J Invest Dermatol 1963: 41: 451-456.
21. Cormane Rh. Bound globulin in the skin of patients with chronic discoid lupus erythematosus and systemic lupus erythematosus. Lancet 1964: 1: 534-535.
22. Bean S F, Lynch F W. Senear-Usher Syndrome (Pemphigus erythematosus) Immunofluorescent studies in a patient. Arch Dermatol 1970: 101: 642-645.
23. Jablonska S, Chorzelski T, Maciejowska E. The scope and limitations of the immunofluorescence method in the diagnosis of lupus erythematosus. Br J Dermatol 1970: 83: 242-247.
24. Wojnarowska F, Bhogal B, Black M M. The significance of an IgM band at the dermo-epidermal junction. J Cutan Pathol 1986: 13: 359-362.
25. Giannetti A. Immunofluorescence studies in the Senear Usher syndrome. Arch Derm Forsch 1974: 248: 287-296.
26. Foedinger D, Sterniczky B, Elbe A, Anhalt G J, Wolff K, Rappersberger K. Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major. J Invest Derm 1996: 106: 1012-1016.
27. Helou J, Allbritton J, Anhalt G J. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 1995: 32: 441-447.
28. Gammon W R, Briggaman R A, Inman A O, Queen L L, Wheeler C E. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0M sodium chloride-separated skin. J Invest Dermatol 1984: 82: 139-144.
29. Lenz P, Amagai M, Volc-Platzer B, Stingl G, Kirnbauer R. Desmoglein 3-ELISA: A pemphigus vulgaris-specific diagnostic tool. Arch Dermatol 1999: 135: 143-148.
30. Husz S, Kiss M, Molnar K, et al. Development of a system for detection of circulating antibodies against hemidesmosomal proteins in patients with bullous pemphigoid. Arch Dermatol Res 2000: 292: 217-224.
31. Hashimoto T, Ogawa M M, Konohana A, Nishikawa T. Detection of pemphigus vulgaris, and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 1990: 94: 327-331.
32. Matsumura K, Amagai M, Nishikawa T, Hashimoto T. The majority of bullous pemphigoid and herpes gestationis sera react with the NC16a domain of the 180 kDa bullous pemphigoid antigen. Arch Dermatol Res 1996: 288: 507-509.
33. Hamada T, Nagata Y, Tomita M, Salmhofer W, Hashimoto T. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule. Exp Dermatol 2001: 10: 256-263.
34. Nagata Y, Karashima T, Watt F M, Salmhofer W, Kanzaki T, Hashimoto T. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the C-terminal homologous domain of periplakin. J Invest Dermatol 2001: 116: 556-563.
35. Stanley J R, Hawley-Nelson P, Yuspa S H, Shevach E M, Katz S I. Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epithelia. Cell 1981: 24: 897-903.
36. Hashimoto T, Amagai M, Watanabe K, et al. Characterisation of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995: 104: 829-834.
37. Stanley J R. Bullous pemphigoid. In: Freedberg I M, Eisen A Z, Wolff K et al., eds. Dermatology in General Medicine, 5th edn. New York, NY: McGraw-Hill, 1999; 666-673.
38. Korman N J, Stanley J R, Woodley D T. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen. Arch Dermatol 1991: 127: 387-390.
39. Matsubara K, Kanauchi H, Tanaka T, Imamura S. Coexistence of pemphigus and bullous pemphigoid. J Dermatol 1995: 22: 68-71.
40. Chorzelski T P, Maciejowski E, Jablonska S, et al. Coexistence of pemphigus and bullous pemphigoid. Arch Dermatol 1974: 109: 849-853.
41. Harrington C I, Sneddon I B. Coexistence of bullous pemphigoid and pemphigus foliaceus. Br J Dermatol 1979: 100: 441-445.
42. Rantanen T, Niemi K M. A further case of coexisting bullous pemphigus foliaceus. Br J Dermatol 1979: 101: 611-612.
43. Leibovici V, Ron N, Goldenhersh M, Holubar K. Coexistence of pemphigus and bullous pemphigoid. Int J Dermatol 1989: 28: 259-260.
44. Borradori L, Trueb R M, Jaunin F, Limat A, Favre B, Saurat J H. Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family. J Invest Dermatol 1998: 111: 338-340.
45. Ghohestani R, Joly P, Gilbert D, et al. Autoantibody formation against a 190 kDa antigen of the desmosomal plaque in pemphigus foliaceus. Br J Dermatol 1997: 137: 774-779.
46. Joly P, Gilbert D, Thomine E, et al. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus. J Invest Dermatol 1997: 108: 469-475.
47. Kazerounian S, Mahoney M G, Uitto J, Aho S. Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies. J Invest Dermatol 2000: 115: 505-507.
48. Robinson N D, Hashimoto T, Amagai M, Chan L S. The new pemphigus variants. J Am Acad Dermatol 1999: 40: 649-673.
49. Amerian M L, Ahmed A R. Pemphigus erythematosus presentation of four cases and review of the literature. J Am Acad Dermatol 1984: 10: 215-222.
50. Livden J K, Naevdal A, Milde E J. Pemphigus in rheumatoid arthritis treated with penicillamine. Scand J Rheumatol 1981: 10: 95-96.
51. Sontheimer R D, Provost T T. Lupus erythemaosus. In: Sontheimer R D, Provost T T, eds. Cutaneous Manifestations of Rheumatic Diseases. Baltimore: Williams & Wilkins, 1996.